Javascript must be enabled to continue!
Benefits of monitoring plasma levodopa in Parkinson's disease patients with drug‐induced chorea
View through CrossRef
AbstractWe studied the temporal patterns of chorea and plasma levodopa profiles in 30 patients with Parkinson's disease whose motor fluctuations were difficult to characterize and treat on the basis of observation alone. We were able to determine whether chorea was associated with high levodopa concentrations or low levodopa concentrations or both. We found the following patterns of levodopa‐associated chorea: chorea due to inadequate levodopa levels, chorea due to biphasic levodopa absorption, chorea associated with either rapid or slow levodopa absorption, and chorea due to long‐duration levodopa absorption mimicking a sustained‐release preparation. Seven patients benefited after their dosing schedules were rearranged as a result of information gained from monitoring. We conclude that any patient with levodopa‐associated chorea who cannot be regulated on the basis of observation alone should be studied with simultaneous plasma levodopa measurements and clinical monitoring to detect an unusual plasma levodopa pattern that may be improved by adjustment of dosing schedule.
Title: Benefits of monitoring plasma levodopa in Parkinson's disease patients with drug‐induced chorea
Description:
AbstractWe studied the temporal patterns of chorea and plasma levodopa profiles in 30 patients with Parkinson's disease whose motor fluctuations were difficult to characterize and treat on the basis of observation alone.
We were able to determine whether chorea was associated with high levodopa concentrations or low levodopa concentrations or both.
We found the following patterns of levodopa‐associated chorea: chorea due to inadequate levodopa levels, chorea due to biphasic levodopa absorption, chorea associated with either rapid or slow levodopa absorption, and chorea due to long‐duration levodopa absorption mimicking a sustained‐release preparation.
Seven patients benefited after their dosing schedules were rearranged as a result of information gained from monitoring.
We conclude that any patient with levodopa‐associated chorea who cannot be regulated on the basis of observation alone should be studied with simultaneous plasma levodopa measurements and clinical monitoring to detect an unusual plasma levodopa pattern that may be improved by adjustment of dosing schedule.
Related Results
Evaluation of Patients with an Initial Diagnosis of Chorea: Sydenham Chorea and Differential Diagnoses
Evaluation of Patients with an Initial Diagnosis of Chorea: Sydenham Chorea and Differential Diagnoses
Objective: Our aim is to evaluate patients being referred with an initial diagnosis of chorea according to their clinical, laboratory features and final diagnoses while emphasizing...
Plasma Concentration of Levodopa in Patients with Parkinson’s Disease
Plasma Concentration of Levodopa in Patients with Parkinson’s Disease
Responses in plasma concentration of levodopa to administration of levodopa alone or combined with the extracerebral decarboxylase inhibitor, Ro 4-4602, were studied in 173 parkins...
Sydenham's Chorea in Western Pennsylvania
Sydenham's Chorea in Western Pennsylvania
OBJECTIVE. Chorea is characterized by involuntary, fleeting, irregular, nonrhythmic movements that flow from 1 body region to another. There are many causes of childhood chorea, in...
Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia
Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia
AbstractBackgroundLevodopa‐induced dyskinesias are an often debilitating side effect of levodopa therapy in Parkinson's disease. Although up to 90% of individuals with PD develop t...
Modulatory Effect of Levodopa on the Basal Ganglia-Cerebellum Connectivity in Parkinson’s Disease
Modulatory Effect of Levodopa on the Basal Ganglia-Cerebellum Connectivity in Parkinson’s Disease
Abstract
Levodopa has remained the mainstay of medical therapy for Parkinson’s disease since its development in the 1980s. However, long-term medication use is asso...
Primary Combination Therapy of Early Parkinson’s Disease
Primary Combination Therapy of Early Parkinson’s Disease
The aim of this multicenter randomized prospective study in patients with early Parkinson’s disease is to differentiate over a 4-year period between levodopa/benserazide monotherap...
Involuntary Movements
Involuntary Movements
Abstract
Choreiform involuntary movements, “dyskinesia,” are a manifestation of chronic levodopa treatment in Parkinson’s disease. Levodopa-induced chorea presents a...
Impact of a public health policy on accessibility to levodopa for people with Parkinson’s disease in Brazil
Impact of a public health policy on accessibility to levodopa for people with Parkinson’s disease in Brazil
Abstract
Background
Access to levodopa remains limited in many low- and middle-income countries. Brazil’s Popular Pharmacy Prog...

